Different kinetics of WT1 and PML-RARalpha gene expression levels during remission induction therapy with all-trans retinoic acid alone in acute promyelocytic leukemia

Int J Hematol. 2006 Dec;84(5):468-70. doi: 10.1532/IJH97.06161.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Antineoplastic Agents / administration & dosage*
  • Gene Expression Regulation, Leukemic* / drug effects
  • HL-60 Cells
  • Humans
  • Leukemia, Promyelocytic, Acute / drug therapy
  • Leukemia, Promyelocytic, Acute / metabolism*
  • Leukemia, Promyelocytic, Acute / pathology
  • Male
  • Middle Aged
  • Oncogene Proteins, Fusion / biosynthesis*
  • Remission Induction
  • Time Factors
  • Tretinoin / administration & dosage*
  • WT1 Proteins / biosynthesis*

Substances

  • Antineoplastic Agents
  • Oncogene Proteins, Fusion
  • WT1 Proteins
  • promyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein
  • Tretinoin